U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 5260

1.
The Impact of Tumor Laterality (Unilateral vs. Bilateral) on Presentation and Management Outcome in Patients with Retinoblastoma
Mona Mohammad, Mustafa Mehyar, Hadeel Halalsheh, Reham Shehada, Omar Al Adawi, Jakub Khzouz, Imad Jaradat, Maysa Al-Hussaini, Iyad Sultan, Ibrahim Alnawaiseh, Yacoub A. Yousef
J Clin Med. 2024 Apr; 13(7): 2146. Published online 2024 Apr 8. doi: 10.3390/jcm13072146
PMCID:
PMC11012679
ArticlePDF–237K
2.
The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers
Ayat Lashen, Mashael Algethami, Shatha Alqahtani, Ahmed Shoqafi, Amera Sheha, Jennie N. Jeyapalan, Nigel P. Mongan, Emad A. Rakha, Srinivasan Madhusudan
Int J Mol Sci. 2024 Apr; 25(7): 4060. Published online 2024 Apr 5. doi: 10.3390/ijms25074060
PMCID:
PMC11012085
ArticlePDF–6.1M
3.
Effects of saponins Rb1 and Re in American ginseng combined intervention on immune system of aging model
Mao Shi, Jie Ma, Shan Jin, Tienan Wang, Yuhan Sui, Lina Chen
Front Mol Biosci. 2024; 11: 1392868. Published online 2024 Mar 28. doi: 10.3389/fmolb.2024.1392868
PMCID:
PMC11007219
ArticlePDF–1.5M
4.
Incidence of second primary cancers in patients with retinoblastoma: a systematic review and meta-analysis
Jinfeng Sun, Xiuli Gu, Liangjun Wang
Front Oncol. 2024; 14: 1372548. Published online 2024 Mar 28. doi: 10.3389/fonc.2024.1372548
PMCID:
PMC11007213
ArticlePDF–2.4M
5.
The clinical value of optical genome mapping in the rapid characterization of RB1 duplication and 15q23q24.2 triplication, for more appropriate prenatal genetic counselling
Malek Bouassida, Denise Molina‐Gomes, Fairouz Koraichi, Bérénice Hervé, Morgane Lhuilier, Clémence Duvillier, Jessica Le Gall, Marion Gauthier‐Villars, Valérie Serazin, Thibaud Quibel, Rodolphe Dard, François Vialard
Mol Genet Genomic Med. 2024 Apr; 12(4): e2437. Published online 2024 Apr 8. doi: 10.1002/mgg3.2437
PMCID:
PMC11000809
ArticlePDF–940K
6.
New retinoblastoma (RB) drug delivery approaches: anti‐tumor effect of atrial natriuretic peptide (ANP)‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treatment of chemoresistant RB
André Haase, Natalia Miroschnikov, Stefan Klein, Annika Doege, Nicole Dünker, Dario Van Meenen, Andreas Junker, Achim Göpferich, Paola Stephanie Apaolaza, Maike Anna Busch
Mol Oncol. 2024 Apr; 18(4): 832–849. Published online 2024 Jan 12. doi: 10.1002/1878-0261.13587
PMCID:
PMC10994242
ArticlePDF–8.4M
7.
Ceftriaxone exerts antitumor effects in MYCN‐driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression
Pamorn Chittavanich, Duangporn Saengwimol, Sittiruk Roytrakul, Duangnate Rojanaporn, Vijender Chaitankar, Atthapol Srimongkol, Usanarat Anurathapan, Suradej Hongeng, Rossukon Kaewkhaw
Mol Oncol. 2024 Apr; 18(4): 918–938. Published online 2023 Nov 27. doi: 10.1002/1878-0261.13553
PMCID:
PMC10994227
ArticlePDF–6.2M
8.
[Retracted] Serum miR‑338‑5p has potential for use as a tumor marker for retinoblastoma
Peng Zhou, Xuemin Li
Oncol Lett. 2024 May; 27(5): 215. Published online 2024 Mar 19. doi: 10.3892/ol.2024.14347
Retracts:
Oncol Lett. 2019 Jul; 18(1): 307–313.
PMCID:
PMC10988189
RetractionPDF–243K
9.
miR-889-3p targeting BMPR2 promotes the development of retinoblastoma via JNK/MAPK/ERK signaling
Yuan Gao, Pei Du
Sci Rep. 2024; 14: 7277. Published online 2024 Mar 27. doi: 10.1038/s41598-023-49994-2
PMCID:
PMC10973389
ArticlePDF–6.3M
10.
Retracted: hsa_circ_0084811 Regulates Cell Proliferation and Apoptosis in Retinoblastoma through miR-18a-5p/miR-18b-5p/E2F5 Axis
BioMed Research International
Biomed Res Int. 2024; 2024: 9805059. Published online 2024 Mar 20. doi: 10.1155/2024/9805059
Retracts:
Biomed Res Int. 2022; 2022: 6918396.
PMCID:
PMC10973242
RetractionPDF–514K
11.
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion
Diana Malarikova, Radek Jorda, Kristyna Kupcova, Jana Senavova, Alexandra Dolnikova, Eva Pokorna, Dmitry Kazantsev, Kristina Nozickova, Dana Sovilj, Celine Bellanger, David Chiron, Ladislav Andera, Vladimir Krystof, Miroslav Strnad, Karel Helman, Magdalena Klanova, Marek Trneny, Ondrej Havranek, Pavel Klener
Exp Hematol Oncol. 2024; 13: 34. Published online 2024 Mar 25. doi: 10.1186/s40164-024-00499-2
PMCID:
PMC10962182
ArticlePDF–1016K
12.
Carbon quantum dots of ginsenoside Rb1 for application in a mouse model of intracerebral Hemorrhage
Xiaolong Tang, Xinyu Yang, Yamei Yu, Miaojing Wu, Yuanyuan Li, Zhe Zhang, Guangyu Jia, Qi Wang, Wei Tu, Ye Wang, Xingen Zhu, Shiyong Li
J Nanobiotechnology. 2024; 22: 125. Published online 2024 Mar 22. doi: 10.1186/s12951-024-02368-w
PMCID:
PMC10958843
ArticlePDF–2.9M
13.
LncRNA NEAT1 promotes angiogenesis of retinoblastoma cells through regulation of the miR-106a/HIF-1α axis
Ying Liu, Zhiyuan Xin, Kun Zhang, Xin Jin, Dajiang Wang
Heliyon. 2024 Mar 30; 10(6): e27653. Published online 2024 Mar 9. doi: 10.1016/j.heliyon.2024.e27653
PMCID:
PMC10958356
ArticlePDF–7.8M
14.
Risk factors for cataract in retinoblastoma management
Shichong Jia, Xuyang Wen, Jie Yu, Min Zhou, Ludi Yang, Yiyi Feng, Xiaoyu He, Renbing Jia, Jiayan Fan, Xianqun Fan
Br J Ophthalmol. 2024 Apr; 108(4): 571–577. Published online 2023 Apr 17. doi: 10.1136/bjo-2022-321723
PMCID:
PMC10958276
ArticlePDF–970K
15.
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer
Yasutaka Yamada, Varadha Balaji Venkadakrishnan, Kei Mizuno, Martin Bakht, Sheng-Yu Ku, Maria Mica Garcia, Himisha Beltran
Sci Transl Med. Author manuscript; available in PMC 2024 Mar 20.
Published in final edited form as: Sci Transl Med. 2023 Nov 15; 15(722): eadf6732. Published online 2023 Nov 15. doi: 10.1126/scitranslmed.adf6732
PMCID:
PMC10954288
ArticlePDF–3.8M
16.
Integration of 16S rRNA sequencing and metabolomics to investigate the modulatory effect of ginsenoside Rb1 on atherosclerosis
Yuqin Liang, Jiaqi Fu, Yunhe Shi, Xin Jiang, Fang Lu, Shumin Liu
Heliyon. 2024 Mar 30; 10(6): e27597. Published online 2024 Mar 5. doi: 10.1016/j.heliyon.2024.e27597
PMCID:
PMC10945261
ArticlePDF–7.1M
17.
Low expression of NR1D1 and NR2E3 is associated with advanced features of retinoblastoma
Jie Ding, Jie Sun, Rui-Qi Ma, Ke Zheng, Yi-Nan Han
Int Ophthalmol. 2024; 44(1): 133. Published online 2024 Mar 14. doi: 10.1007/s10792-024-03055-3
PMCID:
PMC10937757
ArticlePDF–1.3M
18.
Strabismus management in retinoblastoma survivors
Babak Masoomian, Carol L. Shields, Hamid Riazi Esfahani, Atefeh Khalili, Fariba Ghassemi, Pukhraj Rishi, Mohammad Reza Akbari, Masoud Khorrami-Nejad
BMC Ophthalmol. 2024; 24: 114. Published online 2024 Mar 13. doi: 10.1186/s12886-024-03379-9
PMCID:
PMC10935820
ArticlePDF–1.0M
19.
Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism
Kang-Xi Zhang, Yue Zhu, Shu-Xia Song, Qing-Yun Bu, Xiao-Yan You, Hong Zou, Guo-Ping Zhao
Molecules. 2024 Mar; 29(5): 1108. Published online 2024 Mar 1. doi: 10.3390/molecules29051108
PMCID:
PMC10934602
ArticlePDF–5.6M
20.
Retinoblastoma Incidence in Taiwan Over a Recent 20-Year Period: A Comprehensive Nationwide Study
Hsin-Ying Lin, Chung-Han Ho, Yu-Shiuan Lin, Shu-Chun Kuo, Yi-Chen Chen, Yung-Jen Cheng
Int J Gen Med. 2024; 17: 909–917. Published online 2024 Mar 8. doi: 10.2147/IJGM.S452277
PMCID:
PMC10929645
ArticlePDF–3.1M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center